World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00547053
Date of registration: 17/10/2007
Prospective Registration: No
Primary sponsor: Children's Hospital Boston
Public title: Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
Scientific title: A Six Month Open Label Study of Amiloride Solution for Inhalation and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
Date of first enrolment: December 2006
Target sample size: 25
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00547053
Study type:  Interventional
Study design:  Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 1
Countries of recruitment
United States
Contacts
Name:     Dawn Ericson, MD
Address: 
Telephone:
Email:
Affiliation:  Children's Hospital Boston
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of Cystic Fibrosis

- Two positive cultures for Burkholderia dolosa lung infection

Exclusion Criteria:

- Positive pregnancy test or currently breast feeding (if applicable)

- Known sensitivity to Amiloride



Age minimum: 6 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Cystic Fibrosis
Intervention(s)
Drug: Amiloride Solution for Inhalation
Primary Outcome(s)
Eradication of Burkholderia dolosa. [Time Frame: 1 month, 3 months, and 6 months]
Secondary Outcome(s)
Secondary ID(s)
06-06-0290
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Cystic Fibrosis Foundation Therapeutics
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history